| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.004 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |